TITLE

The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge

AUTHOR(S)
Frye, T. D.; Chiou, H. C.; Hull, B. E.; Bigley, N. J.
PUB. DATE
September 2002
SOURCE
Archives of Virology;Sep2002, Vol. 147 Issue 9, p1747
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Summary. Antiviral effects of a DNA vaccine against herpes simplex virus 1 (HSV-1) glycoprotein D (gD) were evaluated in eight week-old female BALB/c mice. The nuclease-insensitive construct (gD-ASOR) consisted of an HSV-1 gD encoding plasmid coupled to asialo orosomucoid (ASOR), targeting it to cells bearing ASOR receptors. Mice were immunized on day 0 and 7 with 10 μg doses of gD-ASOR or control substances. Fourteen days later, mice were infected by the corneal route with 105 pfu or 106 pfu HSV-1, strain 17syn+. Immunized mice showed a significant decrease in ocular disease severity over a 21-day observation period following infection compared to sham-immunized mice. Acute replication kinetic assays demonstrated a 100-fold decrease in viral titers on day 6 in trigeminal ganglia from immunized BALB/c mice compared to sham-immunized mice. Immunized mice showed a significant increase in numbers of CD4+T cells infiltrating the trigeminal ganglia at day 6 post infection compared to sham-immunized mice. Significant differences were not seen in latent viral reservoir between immunized and unimmunized mouse groups. Immunization with gD-ASOR decreased the severity of acute ocular HSV-1 infection, induced a CD4+ T cell response, decreased the viral load in the trigeminal ganglia, but did not diminish viral latency.
ACCESSION #
15396191

 

Related Articles

  • Keeping Herpes Under Control. Wilhelmus, Kirk R. // Review of Ophthalmology;Nov2003 Part 1 of 2, Vol. 10 Issue 11, p76 

    Examines ocular herpes simplex virus (HSV). Treatment of HSV; Role of herpes on ocular effects; Effectiveness of antiviral prophylaxis in preventing recurrences of HSV disease. INSET: HEDS Sheds Light on Herpes.

  • HERPES SIMPLEX VIRUS EPITHELIAL KERATITIS.  // Review of Optometry;4/15/2008 Supplement, Vol. 145, p22A 

    The article offers information about herpes simplex virus (HSV) epithelial keratitis, which occurs in children with bilateral involvement. The HSV infection involves a dendritic ulceration of the corneal epithelium accompanied by a stromal keratitis. This disease can be treated with 1% of...

  • Comparison of the sensitivity of a 24 h-shell vial assay, and conventional tube culture, in the isolation of Herpes simplex virus - 1 from corneal scrapings. Athmanathan, Sreedharan; Bandlapally, Sesha Reddy; Rao, Gullapalli N. // BMC Clinical Pathology;2002, Vol. 2, p1 

    Background: Herpes simplex keratitis is a sight threatening ocular infection. A rapid and specific diagnosis is essential for the institution of specific antiviral therapy and to avoid complications that can arise from misdiagnosis and inappropriate treatment. Though a variety of techniques are...

  • A functional type I interferon pathway drives resistance to cornea herpes simplex virus type 1 infection by recruitment of leukocytes Conrady, Christopher D.; Jones, Heather; Zheng, Min; Carr, Daniel J.J. // Journal of Biomedical Research;Mar2011, Vol. 25 Issue 2, p111 

    Abstract: Type I interferons are critical antiviral cytokines produced following herpes simplex virus type-1 (HSV-1) infection that act to inhibit viral spread. In the present study, we identify HSV-infected and adjacent uninfected corneal epithelial cells as the source of interferon-α. We...

  • Dipeptide Monoester Ganciclovir Prodrugs for Treating HSV-1-Induced Corneal Epithelial and Stromal Keratitis: In Vitro and In Vivo Evaluations. Majumdar, Soumyajit; Nashed, Yasser E.; Patel, Kunal; Jain, Ritesh; Itahashi, Motoki; Neumann, Donna M.; Hill, James M.; Mitra, Ashim K. // Journal of Ocular Pharmacology & Therapeutics;Dec2005, Vol. 21 Issue 6, p463 

    Purpose: The aim of this study was to evaluate a series of dipeptide monoester ganciclovir (GCV) prodrugs with the goal of improving ocular bioavailability of GCV from topical ophthalmic solutions. Methods: Solubility, logP, pH-stability profile, permeability, interaction with corneal peptide...

  • A Cationic TAT Peptide Inhibits Herpes Simplex Virus Type 1 Infection of Human Corneal Epithelial Cells. Larsen, Inna V.; Brandt, Curtis R. // Journal of Ocular Pharmacology & Therapeutics;Dec2010, Vol. 26 Issue 6, p541 

    Purpose: To determine if a peptide, TAT-Cd0, inhibits Herpes simplex virus type 1 infection of human corneal epithelial cells. Methods: TAT-Cd0 and a control peptide, E50,51TAT-Cd0, were added at various times throughout infection with the lacz-expressing hrR3 virus, and viral replication was...

  • Treatment of Common Cutaneous Herpes Simplex Virus Infections. Emmert, Davis H. // American Family Physician;3/15/2000, Vol. 61 Issue 6, p1697 

    Presents information on antiviral drugs for herpes simplex virus (HSV). Diagnosis of genital HSV infection; Details on genital HSV; Information on orolabial herpes.

  • Current clinical practice of consultant ophthalmologists in treating herpetic eye disease in the United Kingdom. Ziahosseini, K.; Ikram, K. // Eye;Apr2009, Vol. 23 Issue 4, p993 

    PurposeHerpes simplex virus continues to be a leading cause of chronic corneal opacification and unilateral blindness. No similar studies have been previously conducted in the United Kingdom.MethodsA 12-question circular was posted to 903 consultant ophthalmologists. It evaluated treatment...

  • Pseudodendrites.  // Review of Optometry;1/15/2006 Supplement, Vol. 143, p18 

    The article presents a discussion on pseudodendrites. They are epithelial-based lesions found in interconnected creases of corneal surface. The difference between pseudodendrites and herpes simplex virus dendrite is that pseudodendrite is more linear with a horizontal or double-ended "Y" and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics